Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RLAY
#1750
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+14.77%
Mudança mensal
+21.42%
Mudança em 6 meses
+185.79%
Mudança anual
+213.76%
Fechamento anterior
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
Volume
219
Mercados
Ações
Cuidados de saúde
RLAY
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
90.4 M
108.28 M
121.38 M
131.18 M
169.52 M
178.73 M
—
Valuation ratios
Enterprise value
3.85 B
3.05 B
1.67 B
1.41 B
574.14 M
1.43 B
3.08 B
Price to earnings ratio
—
—
-5.81
-4.25
-1.75
-5.25
-11.28
Price to sales ratio
—
—
1 222.3
56.88
58.82
—
—
Price to cash flow ratio
—
—
7.36
4.84
2.36
6.17
13.04
Price to book ratio
—
—
1.78
1.93
0.76
2.56
3.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.36
0.26
0.41
0.39
0.44
0.39
Return on equity %
0.07
0.41
0.31
0.45
0.43
0.49
0.43
Return on invested capital %
65.63
278.88
147.72
187.57
214.71
197.28
—
Gross margin %
100
100
100
100
100
100
—
Operating margin %
67.51
1 204.02
21.67 K
1 460.11
3 722.07
1 971.59
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
63.41
1 201.29
21.04 K
1 338.66
3 374.72
1 800.58
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
56.49
40.14
16
25.44
15.95
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.1
0.03
0
0.03
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.04
2.45
1.74
1.37
1.38
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.35
1.17
0.87
0.49
2.24
Net current asset value per share
—
—
9.08
6.28
5.66
3.37
15.33
Tangible book value per share
—
—
8.45
6.12
5.43
3.3
14.96
Working capital per share
—
—
8.52
6.04
5.31
3.22
14.59
Book value per share
—
—
8.47
6.13
5.44
3.3
14.98
Notícias
Relay Therapeutics stock hits 52-week high at 9.64 USD
Lucro da Relay superou projeções por $0,09; receita supera estimativas
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Relay Therapeutics divulga resultados após avanço regulatório da FDA
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech apresenta lucro 660% maior em 2025, mas projeta cautela para 2026
Relay earnings in focus as FDA breakthrough fuels optimism
Ações da Relay Therapeutics sobem após FDA conceder status de Terapia Inovadora
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
FDA concede status de terapia inovadora ao medicamento da Relay para câncer de mama
FDA grants breakthrough therapy status to Relay’s breast cancer drug